1-3 of 3
Zhaoli Liu
Close
Sort by
Journal Articles

T Cell Selection Is Not Helpful for Therapeutic Efficacy of CART19 in Relapsed or Refractory B-ALL Patients with Peripheral Blood Leukemia Burden at Time of Apheresis

Biping Deng, Zhaoli Liu, Jing PAN, Shuangyou Liu, Xiaoming Qu, Yu'e Zhang, Lingli Zhang, Ming Ma, Zhongxin Zhang, Xinjian Yu, Qinlong Zheng, Chunrong Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 6943.
https://doi.org/10.1182/blood-2023-180359
Published: 2023
Journal Articles

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Biping Deng, BS, MD, Jing Pan, Shuangyou Liu, Yuehui Lin, Zhaoli Liu, Yunlong Chen, Xiaoming Qu, Yu 'e Zhang, Zhongxin Zhang, Xuansha Niu, Ming Ma, Tong Wu, MD, Alex Hong Chang, Chunrong Tong
Journal: Blood
Blood (2019) 134 (Supplement_1): 1957.
https://doi.org/10.1182/blood-2019-126695
Published: 2019
Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD
Journal: Blood
Blood (2016) 128 (22): 649.
https://doi.org/10.1182/blood.V128.22.649.649
Published: 2016